Valsartan, an angiotensin II receptor blocker drug, delayed disease progression and improved cardiac structure and function in patients with early-stage hypertrophic cardiomyopathy, according to ...
Amsterdam, NL, February, 26. 2015 - The muscular dystrophies are known to target various muscle groups differentially. In addition to making limb muscles weak, muscular dystrophy (MD) can also lead to ...
Many promising therapies fail because preclinical models do not fully capture the complexity of the human heart. A new review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results